Table of Content

1 Blood Biological Products Market Overview
1.1 Product Overview and Scope of Blood Biological Products
1.2 Blood Biological Products Segment by Type
1.2.1 Global Blood Biological Products Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Blood Biological Products Segment by Application
1.3.1 Blood Biological Products Sales Comparison by Application: (2021-2027)
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Global Blood Biological Products Market Size Estimates and Forecasts
1.4.1 Global Blood Biological Products Revenue 2016-2027
1.4.2 Global Blood Biological Products Sales 2016-2027
1.4.3 Blood Biological Products Market Size by Region: 2016 Versus 2021 Versus 2027

2 Blood Biological Products Market Competition by Manufacturers
2.1 Global Blood Biological Products Sales Market Share by Manufacturers (2016-2021)
2.2 Global Blood Biological Products Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Blood Biological Products Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Blood Biological Products Manufacturing Sites, Area Served, Product Type
2.5 Blood Biological Products Market Competitive Situation and Trends
2.5.1 Blood Biological Products Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Blood Biological Products Players Market Share by Revenue
2.5.3 Global Blood Biological Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Blood Biological Products Retrospective Market Scenario by Region
3.1 Global Blood Biological Products Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Blood Biological Products Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Blood Biological Products Market Facts & Figures by Country
3.3.1 North America Blood Biological Products Sales by Country
3.3.2 North America Blood Biological Products Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Blood Biological Products Market Facts & Figures by Country
3.4.1 Europe Blood Biological Products Sales by Country
3.4.2 Europe Blood Biological Products Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Biological Products Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Biological Products Sales by Region
3.5.2 Asia Pacific Blood Biological Products Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Blood Biological Products Market Facts & Figures by Country
3.6.1 Latin America Blood Biological Products Sales by Country
3.6.2 Latin America Blood Biological Products Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Blood Biological Products Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Biological Products Sales by Country
3.7.2 Middle East and Africa Blood Biological Products Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Blood Biological Products Historic Market Analysis by Type
4.1 Global Blood Biological Products Sales Market Share by Type (2016-2021)
4.2 Global Blood Biological Products Revenue Market Share by Type (2016-2021)
4.3 Global Blood Biological Products Price by Type (2016-2021)

5 Global Blood Biological Products Historic Market Analysis by Application
5.1 Global Blood Biological Products Sales Market Share by Application (2016-2021)
5.2 Global Blood Biological Products Revenue Market Share by Application (2016-2021)
5.3 Global Blood Biological Products Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Takeda Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CSL Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Grifols Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kedrion Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.6.4 LFB Group Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biotest Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BPL Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.9.4 RAAS Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CBPO Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Blood Biological Products Description and Business Overview
6.11.3 Hualan Bio Blood Biological Products Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hualan Bio Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates

7 Blood Biological Products Manufacturing Cost Analysis
7.1 Blood Biological Products Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Biological Products
7.4 Blood Biological Products Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Biological Products Distributors List
8.3 Blood Biological Products Customers

9 Blood Biological Products Market Dynamics
9.1 Blood Biological Products Industry Trends
9.2 Blood Biological Products Growth Drivers
9.3 Blood Biological Products Market Challenges
9.4 Blood Biological Products Market Restraints

10 Global Market Forecast
10.1 Blood Biological Products Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Biological Products by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Blood Biological Products by Type (2022-2027)
10.2 Blood Biological Products Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Blood Biological Products by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Blood Biological Products by Application (2022-2027)
10.3 Blood Biological Products Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Biological Products by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Blood Biological Products by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Blood Biological Products Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Blood Biological Products Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Blood Biological Products Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Blood Biological Products Covered in This Study
Table 5. Global Blood Biological Products Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Blood Biological Products Sales Share by Manufacturers (2016-2021)
Table 7. Global Blood Biological Products Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Blood Biological Products Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Blood Biological Products Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Blood Biological Products Manufacturing Sites and Area Served
Table 11. Manufacturers Blood Biological Products Product Type
Table 12. Global Blood Biological Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Biological Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Biological Products as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Blood Biological Products Sales by Region (2016-2021) & (K Units)
Table 16. Global Blood Biological Products Sales Market Share by Region (2016-2021)
Table 17. Global Blood Biological Products Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Blood Biological Products Sales by Country (2016-2021) & (K Units)
Table 19. North America Blood Biological Products Sales Market Share by Country (2016-2021)
Table 20. North America Blood Biological Products Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Blood Biological Products Revenue Market Share by Country (2016-2021)
Table 22. Europe Blood Biological Products Sales by Country (2016-2021) & (K Units)
Table 23. Europe Blood Biological Products Sales Market Share by Country (2016-2021)
Table 24. Europe Blood Biological Products Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Blood Biological Products Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Blood Biological Products Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Blood Biological Products Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Blood Biological Products Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Blood Biological Products Revenue Market Share by Region (2016-2021)
Table 30. Latin America Blood Biological Products Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Blood Biological Products Sales Market Share by Country (2016-2021)
Table 32. Latin America Blood Biological Products Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Blood Biological Products Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Blood Biological Products Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Blood Biological Products Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Blood Biological Products Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Blood Biological Products Revenue Market Share by Country (2016-2021)
Table 38. Global Blood Biological Products Sales (K Units) by Type (2016-2021)
Table 39. Global Blood Biological Products Sales Market Share by Type (2016-2021)
Table 40. Global Blood Biological Products Revenue (Million US$) by Type (2016-2021)
Table 41. Global Blood Biological Products Revenue Share by Type (2016-2021)
Table 42. Global Blood Biological Products Price (US$/Unit) by Type (2016-2021)
Table 43. Global Blood Biological Products Sales (K Units) by Application (2016-2021)
Table 44. Global Blood Biological Products Sales Market Share by Application (2016-2021)
Table 45. Global Blood Biological Products Revenue (Million US$) by Application (2016-2021)
Table 46. Global Blood Biological Products Revenue Share by Application (2016-2021)
Table 47. Global Blood Biological Products Price (US$/Unit) by Application (2016-2021)
Table 48. Takeda Corporation Information
Table 49. Takeda Description and Business Overview
Table 50. Takeda Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Takeda Blood Biological Products Product
Table 52. Takeda Recent Developments/Updates
Table 53. CSL Corporation Information
Table 54. CSL Description and Business Overview
Table 55. CSL Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. CSL Blood Biological Products Product
Table 57. CSL Recent Developments/Updates
Table 58. Grifols Corporation Information
Table 59. Grifols Description and Business Overview
Table 60. Grifols Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Grifols Blood Biological Products Product
Table 62. Grifols Recent Developments/Updates
Table 63. Octapharma Corporation Information
Table 64. Octapharma Description and Business Overview
Table 65. Octapharma Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Octapharma Blood Biological Products Product
Table 67. Octapharma Recent Developments/Updates
Table 68. Kedrion Corporation Information
Table 69. Kedrion Description and Business Overview
Table 70. Kedrion Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Kedrion Blood Biological Products Product
Table 72. Kedrion Recent Developments/Updates
Table 73. LFB Group Corporation Information
Table 74. LFB Group Description and Business Overview
Table 75. LFB Group Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. LFB Group Blood Biological Products Product
Table 77. LFB Group Recent Developments/Updates
Table 78. Biotest Corporation Information
Table 79. Biotest Description and Business Overview
Table 80. Biotest Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Biotest Blood Biological Products Product
Table 82. Biotest Recent Developments/Updates
Table 83. BPL Corporation Information
Table 84. BPL Description and Business Overview
Table 85. BPL Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. BPL Blood Biological Products Product
Table 87. BPL Recent Developments/Updates
Table 88. RAAS Corporation Information
Table 89. RAAS Description and Business Overview
Table 90. RAAS Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. RAAS Blood Biological Products Product
Table 92. RAAS Recent Developments/Updates
Table 93. CBPO Corporation Information
Table 94. CBPO Description and Business Overview
Table 95. CBPO Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. CBPO Blood Biological Products Product
Table 97. CBPO Recent Developments/Updates
Table 98. Hualan Bio Corporation Information
Table 99. Hualan Bio Description and Business Overview
Table 100. Hualan Bio Blood Biological Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Hualan Bio Blood Biological Products Product
Table 102. Hualan Bio Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Blood Biological Products Distributors List
Table 106. Blood Biological Products Customers List
Table 107. Blood Biological Products Market Trends
Table 108. Blood Biological Products Growth Drivers
Table 109. Blood Biological Products Market Restraints
Table 110. Global Blood Biological Products Sales Forecast by Type (2022-2027) & (K Units)
Table 111. Global Blood Biological Products Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Blood Biological Products Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Blood Biological Products Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Blood Biological Products Sales Forecast by Application (2022-2027) & (K Units)
Table 115. Global Blood Biological Products Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Blood Biological Products Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Blood Biological Products Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Blood Biological Products Sales Forecast by Region (2022-2027) & (K Units)
Table 119. Global Blood Biological Products Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Blood Biological Products Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Blood Biological Products Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Biological Products
Figure 2. Global Blood Biological Products Market Share by Type in 2020 & 2027
Figure 3. Coagulation Factor Product Picture
Figure 4. Immune Globulin Product Picture
Figure 5. Albumin Product Picture
Figure 6. Other Product Picture
Figure 7. Global Blood Biological Products Market Share by Application in 2020 & 2027
Figure 8. Immunology
Figure 9. Hematology
Figure 10. Other
Figure 11. Global Blood Biological Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Blood Biological Products Market Size 2016-2027 (US$ Million)
Figure 13. Global Blood Biological Products Sales 2016-2027 (K Units)
Figure 14. Global Blood Biological Products Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Blood Biological Products Sales Share by Manufacturers in 2020
Figure 16. Global Blood Biological Products Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Blood Biological Products Players: Market Share by Revenue in 2020
Figure 18. Blood Biological Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Blood Biological Products Sales Market Share by Region (2016-2021)
Figure 20. Global Blood Biological Products Sales Market Share by Region in 2020
Figure 21. Global Blood Biological Products Revenue Market Share by Region (2016-2021)
Figure 22. Global Blood Biological Products Revenue Market Share by Region in 2020
Figure 23. U.S. Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Blood Biological Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Blood Biological Products by Type (2016-2021)
Figure 48. Sales Market Share of Blood Biological Products by Application (2016-2021)
Figure 49. Sales Market Share of Blood Biological Products by Application in 2020
Figure 50. Revenue Share of Blood Biological Products by Application (2016-2021)
Figure 51. Revenue Share of Blood Biological Products by Application in 2020
Figure 52. Manufacturing Cost Structure of Blood Biological Products
Figure 53. Manufacturing Process Analysis of Blood Biological Products
Figure 54. Blood Biological Products Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed